MRK: Approves KEYTRUDA
European Commission approves KEYTRUDA plus Padcev for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.